A Study of AND017 in Cancer Related Anemic Patients Receiving Chemotherapy
Status:
Not yet recruiting
Trial end date:
2026-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of AND017 after 6 weeks of
treatment in patients with cancer-related anemia who are receiving chemotherapy.